CRL-1336: Began a Phase I trial

CytRx Corp. (CYTR), Atlanta Product: CRL-1336, blocker of the P-glycoprotein cell membrane protein, which acts as a pump in tumor cell membranes to eject chemotherapeutics Indication: Relapsed or refr...